Hans et al. divided DLBCL into GCB and non-GCB subgroups by using immunostaining for CD10, bcl-6, and MUM1 and found an outcome similar to that predicted by cDNA microarray analysis [53]. This evidence concerns the gene MME and diffuse large B-cell lymphoma.